In compliance with current regulations, let us know which audience you belong to:
MGD/DED
Dry Eye Disease (DED) induced by Meibomian Glands Dysfunction (MGD) is a tear film disorder which can be produced by excessive evaporation of tears in over 86% of cases.
This evaporation is induced by the obstruction or malfunction of the Meibomian glands that are located in the eyelids and are responsible for producing the tears lipid layer. When these are obstructed, they do not produce enough oily components for the tear film, which consequently evaporates quicker and causes damage to the ocular surface and eye discomfort.
Suggested Protocols
Legend
Single usage
Joint usage
| Pathology | Technology | Suggested Protocol | |||
|---|---|---|---|---|---|
| > No. Treatments | > Frequency (Days Apart) | ||||
| Pathology> MGD/DED | Technology OPE® IPL | + |
LM® LLLT Red
Blue
Yellow
|
Suggested Protocol > No. Treatments 1 to 3 | > Frequency (Days Apart) 5 to 10 |
| Technology OPE® IPL |
LM® LLLT Red
Blue
Yellow
|
Suggested Protocol > No. Treatments 2 to 4 | > Frequency (Days Apart) 2 to 10 | ||
Scientific Coverage
STONECIPHER, Karl, et al. Combined low level light therapy and intense pulsed light therapy for the treatment of meibomian gland dysfunction. Clinical Ophthalmology (Auckland, NZ), 2019, 13: 993.
GIANNACCARE, Giuseppe, et al. Low-Level Light Therapy Versus Intense Pulsed Light for the Treatment of Meibomian Gland Dysfunction: Preliminary Results From a Prospective Randomized Comparative Study. Cornea, 2022.